Global Crude Heparin Market Research Report 2022

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	106 Pages	QYResearch Group	January, 2022	QYR16951855

Best Price Guarantee
Price	from $2,900
Length	106 Pages
Publisher	QYResearch Group
Published Date	January, 2022
SKU	QYR16951855

Global Crude Heparin Market Research Report 2022

Summary

Due to the COVID-19 pandemic, the global Crude Heparin market size is estimated to be worth US$ 3.75 billion in 2021 and is forecast to a readjusted size of US$ 8.32 billion by 2028 with a CAGR of 10.90% during the review period. Fully considering the economic change by this health crisis, the Europe Crude Heparin market is estimated at US$ 0.79 billion in 2022, while the United States and China are forecast to reach US$ 1.6 billion and US$ 4.34 billion by 2028, respectively. The proportion of the United States is 19.02% in 2022, while Chinese percentage is 51.92%, and it is predicted that China market share will reach 52.18% in 2028.
Pig Intestine Mucosa Heparin accounting for 99.35% of the Crude Heparin global market in 2021, is projected to value US$ 8.23 billion by 2028, growing at a revised 10.83% CAGR in the post-COVID-19 period. While UFH segment is altered to an 4.79% CAGR throughout this forecast period and will hold a share about 10% in 2028.
The global major manufacturers of Crude Heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, and Hepac (Darling Ingredients), etc. In terms of revenue, the global 3 largest players have a 37.46% market share of Crude Heparin in 2021.
This report focuses on Crude Heparin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Crude Heparin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.
Global Crude Heparin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

Segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others

Segment by Application
UFH
LMWH

By Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
South Korea
India
Southeast Asia

Europe
Germany
UK
France
Spain
Italy

South America
Mexico
Brazil
Argentina

Middle East & Africa
Saudi Arabia
UAE
Egypt
Turkey
South Africa

1 Crude Heparin Market Overview: 1.1 Product Overview and Scope of Crude Heparin; 1.2 Crude Heparin Segment by Type; 1.2.1 Global Crude Heparin Sales Growth Rate Comparison by Type (2022-2028); 1.2.2 Pig Intestine Mucosa Heparin; 1.2.3 Bovine Heparin and Others; 1.3 Crude Heparin Segment by Application; 1.3.1 Global Crude Heparin Sales Comparison by Application (2017-2028); 1.3.2 UFH; 1.3.3 LMWH; 1.4 Global Crude Heparin Market Size Estimates and Forecasts; 1.4.1 Global Crude Heparin Revenue 2017-2028; 1.4.2 Global Crude Heparin Sales 2017-2028; 1.4.3 Crude Heparin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Crude Heparin Market Competition by Manufacturers: 2.1 Global Crude Heparin Sales Market Share by Manufacturers (2017-2022); 2.2 Global Crude Heparin Revenue Market Share by Manufacturers (2017-2022); 2.3 Global Crude Heparin Average Price by Manufacturers (2017-2022); 2.4 Manufacturers Crude Heparin Manufacturing Sites, Area Served, Product Type; 2.5 Crude Heparin Market Competitive Situation and Trends; 2.5.1 Crude Heparin Market Concentration Rate; 2.5.2 The Global 5 and 3 Largest Crude Heparin Players Market Share by Revenue; 2.5.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Crude Heparin Retrospective Market Scenario by Region: 3.1 Global Crude Heparin Retrospective Market Scenario in Sales by Region: 2017-2022; 3.2 Global Crude Heparin Retrospective Market Scenario in Revenue by Region: 2017-2022; 3.3 North America Crude Heparin Market Facts & Figures by Country; 3.3.1 North America Crude Heparin Sales by Country; 3.3.2 North America Crude Heparin Revenue by Country; 3.3.3 U.S.; 3.3.4 Canada; 3.4 Europe Crude Heparin Market Facts & Figures by Country; 3.4.1 Europe Crude Heparin Sales by Country; 3.4.2 Europe Crude Heparin Revenue by Country; 3.4.3 Germany; 3.4.4 France; 3.4.5 U.K.; 3.4.6 Italy; 3.4.7 Spain; 3.5 Asia Pacific Crude Heparin Market Facts & Figures by Region; 3.5.1 Asia Pacific Crude Heparin Sales by Region; 3.5.2 Asia Pacific Crude Heparin Revenue by Region; 3.5.3 China; 3.5.4 Japan; 3.5.5 South Korea; 3.5.6 India; 3.5.7 Southeast Asia; 3.6 Latin America Crude Heparin Market Facts & Figures by Country; 3.6.1 Latin America Crude Heparin Sales by Country; 3.6.2 Latin America Crude Heparin Revenue by Country; 3.6.3 Mexico; 3.6.4 Brazil; 3.6.5 Argentina; 3.7 Middle East and Africa Crude Heparin Market Facts & Figures by Country; 3.7.1 Middle East and Africa Crude Heparin Sales by Country; 3.7.2 Middle East and Africa Crude Heparin Revenue by Country; 3.7.3 Turkey; 3.7.4 Saudi Arabia; 3.7.5 UAE
4 Crude Heparin Historic Market Analysis by Type: 4.1 Global Crude Heparin Sales Market Share by Type (2017-2022); 4.2 Global Crude Heparin Revenue Market Share by Type (2017-2022); 4.3 Global Crude Heparin Price by Type (2017-2022)
5 Crude Heparin Historic Market Analysis by Application
6 Key Companies Profiled: 6.1 Bioiberica; 6.1.1 Bioiberica Corporation Information; 6.1.2 Bioiberica Description and Business Overview; 6.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.1.4 Bioiberica Crude Heparin Product Portfolio; 6.2 Shenzhen Hepalink; 6.2.1 Shenzhen Hepalink Corporation Information; 6.2.2 Shenzhen Hepalink Description and Business Overview; 6.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.2.4 Shenzhen Hepalink Crude Heparin Product Portfolio; 6.3 Sanofi; 6.3.1 Sanofi Corporation Information; 6.3.2 Sanofi Description and Business Overview; 6.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.3.4 Sanofi Crude Heparin Product Portfolio; 6.4 Nanjing King-friend; 6.4.1 Nanjing King-friend Corporation Information; 6.4.2 Nanjing King-friend Description and Business Overview; 6.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.4.4 Nanjing King-friend Crude Heparin Product Portfolio; 6.5 Fengrun Biological Technology; 6.5.1 Fengrun Biological Technology Corporation Information; 6.5.2 Fengrun Biological Technology Description and Business Overview; 6.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.5.4 Fengrun Biological Technology Crude Heparin Product Portfolio; 6.6 Aspen Oss; 6.6.1 Aspen Oss Corporation Information; 6.6.2 Aspen Oss Description and Business Overview; 6.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.6.4 Aspen Oss Crude Heparin Product Portfolio; 6.7 Hebei Changshan Biochemical; 6.7.1 Hebei Changshan Biochemical Corporation Information; 6.7.2 Hebei Changshan Biochemical Description and Business Overview; 6.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.7.4 Hebei Changshan Biochemical Crude Heparin Product Portfolio; 6.8 Changzhou Qianhong; 6.8.1 Changzhou Qianhong Corporation Information; 6.8.2 Changzhou Qianhong Description and Business Overview; 6.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.8.4 Changzhou Qianhong Crude Heparin Product Portfolio; 6.9 Hepac (Darling Ingredients); 6.9.1 Hepac (Darling Ingredients) Corporation Information; 6.9.2 Hepac (Darling Ingredients) Description and Business Overview; 6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Portfolio; 6.10 Huaian MDC Pharmaceutical; 6.10.1 Huaian MDC Pharmaceutical Corporation Information; 6.10.2 Huaian MDC Pharmaceutical Description and Business Overview; 6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio; 6.11 Yantai Dongcheng Biochemicals; 6.11.1 Yantai Dongcheng Biochemicals Corporation Information; 6.11.2 Yantai Dongcheng Biochemicals Description and Business Overview; 6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2017-2022); 6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
7 Crude Heparin Manufacturing Cost Analysis: 7.1 Crude Heparin Key Raw Materials Analysis; 7.1.1 Key Raw Materials; 7.1.2 Key Raw Materials Price Trend; 7.1.3 Key Suppliers of Raw Materials; 7.2 Proportion of Manufacturing Cost Structure; 7.3 Manufacturing Process Analysis of Crude Heparin; 7.4 Crude Heparin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers: 8.1 Marketing Channel; 8.2 Crude Heparin Distributors List; 8.3 Crude Heparin Customers
9 Crude Heparin Market Dynamics: 9.1 Crude Heparin Industry Growth Opportunities; 9.2 Crude Heparin Market Drivers; 9.3 Crude Heparin Market Challenges and Restraints
10 Global Market Forecast: 10.1 Crude Heparin Market Estimates and Projections by Type; 10.1.1 Global Forecasted Sales of Crude Heparin by Type (2023-2028); 10.1.2 Global Forecasted Revenue of Crude Heparin by Type (2023-2028); 10.2 Crude Heparin Market Estimates and Projections by Application; 10.3 Crude Heparin Market Estimates and Projections by Region; 10.3.1 Global Forecasted Sales of Crude Heparin by Region (2023-2028); 10.3.2 Global Forecasted Revenue of Crude Heparin by Region (2023-2028)
11 Research Findings and Conclusion
12 Methodology and Data Source: 12.1 Methodology/Research Approach; 12.1.1 Research Programs/Design; 12.1.2 Market Size Estimation; 12.1.3 Market Breakdown and Data Triangulation; 12.2 Data Source; 12.2.1 Secondary Sources; 12.2.2 Primary Sources; 12.3 Author List; 12.4 Disclaimer
List of Tables: Table 1. Global Crude Heparin Sales Growth Rate Comparison by Type (2022-2028) & (Tonnes) & (US$ Million); Table 2. Table Detailed Description of Heparin API; Table 3. Global Crude Heparin Sales Growth Rate Comparison by Application (2017-2028) & (Tonnes); Table 4. Global Crude Heparin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028; Table 5. Global Crude Heparin Market Competitive Situation by Manufacturers in 2021; Table 6. Global Crude Heparin Sales (Tonnes) of Key Manufacturers (2017-2022); Table 7. Global Crude Heparin Sales Market Share by Manufacturers (2017-2022); Table 8. Global Crude Heparin Revenue (US$ Million) by Manufacturers (2017-2022); Table 9. Global Crude Heparin Revenue Share by Manufacturers (2017-2022); Table 10. Global Market Crude Heparin Average Price (US$/Kg) of Key Manufacturers (2017-2022); Table 11. Manufacturers Crude Heparin Manufacturing Sites and Area Served; Table 12. Manufacturers Crude Heparin Product Type; Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI); Table 14. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2021); Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans; Table 16. Global Crude Heparin Sales by Region (2017-2022) & (Tonnes); Table 17. Global Crude Heparin Sales Market Share by Region (2017-2022); Table 18. Global Crude Heparin Revenue by Region (2017-2022) & (US$ Million); Table 19. Global Crude Heparin Revenue Market Share by Region (2017-2022); Table 20. North America Crude Heparin Sales by Country (2017-2022) & (Tonnes); Table 21. North America Crude Heparin Sales Market Share by Country (2017-2022); Table 22. North America Crude Heparin Revenue by Country (2017-2022) & (US$ Million); Table 23. North America Crude Heparin Revenue Market Share by Country (2017-2022); Table 24. Europe Crude Heparin Sales by Country (2017-2022) & (Tonnes); Table 25. Europe Crude Heparin Sales Market Share by Country (2017-2022); Table 26. Europe Crude Heparin Revenue by Country (2017-2022) & (US$ Million); Table 27. Europe Crude Heparin Revenue Market Share by Country (2017-2022); Table 28. Asia Pacific Crude Heparin Sales by Region (2017-2022) & (Tonnes); Table 29. Asia Pacific Crude Heparin Sales Market Share by Region (2017-2022); Table 30. Asia Pacific Crude Heparin Revenue by Region (2017-2022) & (US$ Million); Table 31. Asia Pacific Crude Heparin Revenue Market Share by Region (2017-2022); Table 32. Latin America Crude Heparin Sales by Country (2017-2022) & (Tonnes); Table 33. Latin America Crude Heparin Sales Market Share by Country (2017-2022); Table 34. Latin America Crude Heparin Revenue by Country (2017-2022) & (US$ Million); Table 35. Latin America Crude Heparin Revenue Market Share by Country (2017-2022); Table 36. Middle East and Africa Crude Heparin Sales by Country (2017-2022) & (Tonnes); Table 37. Middle East and Africa Crude Heparin Sales Market Share by Country (2017-2022); Table 38. Middle East and Africa Crude Heparin Revenue by Country (2017-2022) & (US$ Million); Table 39. Middle East and Africa Crude Heparin Revenue Market Share by Country (2017-2022); Table 40. Global Crude Heparin Sales by Type (2017-2022) & (Tonnes); Table 41. Global Crude Heparin Sales Market Share by Type (2017-2022); Table 42. Global Crude Heparin Revenue by Type (2017-2022) & (US$ Million); Table 43. Global Crude Heparin Revenue Share by Type (2017-2022); Table 44. Global Crude Heparin Price by Type (2017-2022) & (US$/Kg); Table 45. Global Crude Heparin Sales (Tonnes) by Application (2017-2022); Table 46. Global Crude Heparin Sales Market Share by Application (2017-2022); Table 47. Bioiberica Corporation Information; Table 48. Bioiberica Description and Business Overview; Table 49. Bioiberica Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 50. Bioiberica Crude Heparin Product; Table 51. Shenzhen Hepalink Corporation Information; Table 52. Shenzhen Hepalink Description and Business Overview; Table 53. Shenzhen Hepalink Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 54. Shenzhen Hepalink Crude Heparin Product; Table 55. Sanofi Corporation Information; Table 56. Sanofi Description and Business Overview; Table 57. Sanofi Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 58. Sanofi Crude Heparin Product; Table 59. Nanjing King-friend Corporation Information; Table 60. Nanjing King-friend Description and Business Overview; Table 61. Nanjing King-friend Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 62. Nanjing King-friend Crude Heparin Product; Table 63. Fengrun Biological Technology Corporation Information; Table 64. Fengrun Biological Technology Description and Business Overview; Table 65. Fengrun Biological Technology Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 66. Fengrun Biological Technology Crude Heparin Product; Table 67. Aspen Oss Corporation Information; Table 68. Aspen Oss Description and Business Overview; Table 69. Aspen Oss Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 70. Aspen Oss Crude Heparin Product; Table 71. Hebei Changshan Biochemical Corporation Information; Table 72. Hebei Changshan Biochemical Description and Business Overview; Table 73. Hebei Changshan Biochemical Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 74. Hebei Changshan Biochemical Crude Heparin Product; Table 75. Changzhou Qianhong Corporation Information; Table 76. Changzhou Qianhong Description and Business Overview; Table 77. Changzhou Qianhong Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 78. Changzhou Qianhong Crude Heparin Product; Table 79. Hepac (Darling Ingredients) Corporation Information; Table 80. Hepac (Darling Ingredients) Description and Business Overview; Table 81. Hepac (Darling Ingredients) Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 82. Hepac (Darling Ingredients) Crude Heparin Product; Table 83. Huaian MDC Pharmaceutical Corporation Information; Table 84. Huaian MDC Pharmaceutical Description and Business Overview; Table 85. Huaian MDC Pharmaceutical Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 86. Huaian MDC Pharmaceutical Crude Heparin Product; Table 87. Yantai Dongcheng Biochemicals Corporation Information; Table 88. Yantai Dongcheng Biochemicals Description and Business Overview; Table 89. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022); Table 90. Yantai Dongcheng Biochemicals Crude Heparin Product; Table 91. Key Suppliers of Raw Materials; Table 92. Crude Heparin Distributors List; Table 93. Crude Heparin Customers List; Table 94. Crude Heparin Market Growth Opportunities; Table 95. Crude Heparin Market Drivers; Table 96. Crude Heparin Market Challenges and Restraints; Table 97. Global Crude Heparin Sales Forecast by Type (2023-2028) & (Tonnes); Table 98. Global Crude Heparin Sales Market Share Forecast by Type (2023-2028); Table 99. Global Crude Heparin Revenue Forecast by Type (2023-2028) & (US$ Million); Table 100. Global Crude Heparin Revenue Market Share Forecast by Type (2023-2028); Table 101. Global Crude Heparin Sales Forecast by Application (2023-2028) & (Tonnes); Table 102. Global Crude Heparin Sales Market Share Forecast by Application (2023-2028); Table 103. Global Crude Heparin Sales Forecast by Region (2023-2028) & (Tonnes); Table 104. Global Crude Heparin Sales Market Share Forecast by Region (2023-2028); Table 105. Global Crude Heparin Revenue Forecast by Region (2023-2028) & (US$ Million); Table 106. Global Crude Heparin Revenue Market Share Forecast by Region (2023-2028); Table 107. Research Programs/Design for This Report; Table 108. Key Data Information from Secondary Sources; Table 109. Key Data Information from Primary Sources
List of Figures: Figure 1. Product Picture of Crude Heparin; Figure 2. Global Crude Heparin Revenue Market Share by Type: 2022; Figure 3. Pig Intestine Mucosa Heparin Product Picture; Figure 4. Bovine Heparin and Others Product Picture; Figure 5. Global Crude Heparin Sales Market Share by Application: 2022; Figure 6. UFH; Figure 7. LMWH; Figure 8. Global Crude Heparin Revenue, (US$ Million), 2017 VS 2021 VS 2028; Figure 9. Global Crude Heparin Market Size (2017-2028) & (US$ Million); Figure 10. Global Crude Heparin Sales (2017-2028) & (Tonnes); Figure 11. Crude Heparin Sales Share by Manufacturers in 2021 11